Home › RegulatoryVitaNova Life Sciences Corp - 10-Q FilingVitaNova Life Sciences Corp reported Q2 revenue of $5.2B, up 12% YoY and above guidanceSEC EDGAR · September 14, 2026, 21:08 UTCTickers: $VNOV Read the full article at SEC EDGAR